Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Urinary metabolite profiling identifies biomarkers for risk of progression of diabetic nephropathy in 2,670 individuals with type 1 diabetes

View ORCID ProfileStefan Mutter, View ORCID ProfileErkka Valo, Viljami Aittomäki, Kristian Nybo, Lassi Raivonen, View ORCID ProfileLena M Thorn, View ORCID ProfileCarol Forsblom, View ORCID ProfileNiina Sandholm, View ORCID ProfilePeter Würtz, Per-Henrik Groop
doi: https://doi.org/10.1101/2020.10.21.20215921
Stefan Mutter
1Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland
2Abdominal Center, Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
3Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stefan Mutter
Erkka Valo
1Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland
2Abdominal Center, Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
3Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erkka Valo
Viljami Aittomäki
4Nightingale Health Ltd, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristian Nybo
4Nightingale Health Ltd, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lassi Raivonen
4Nightingale Health Ltd, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lena M Thorn
1Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland
2Abdominal Center, Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
3Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland
5Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lena M Thorn
Carol Forsblom
1Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland
2Abdominal Center, Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
3Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carol Forsblom
Niina Sandholm
1Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland
2Abdominal Center, Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
3Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Niina Sandholm
Peter Würtz
4Nightingale Health Ltd, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter Würtz
Per-Henrik Groop
1Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland
2Abdominal Center, Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
3Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland
6Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: per-henrik.groop@helsinki.fi
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Data Availability

Due to patient privacy and consent, individual level data is not available for this study. The supplementary tables contain aggregated results per study group.

Back to top
PreviousNext
Posted October 25, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Urinary metabolite profiling identifies biomarkers for risk of progression of diabetic nephropathy in 2,670 individuals with type 1 diabetes
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Urinary metabolite profiling identifies biomarkers for risk of progression of diabetic nephropathy in 2,670 individuals with type 1 diabetes
Stefan Mutter, Erkka Valo, Viljami Aittomäki, Kristian Nybo, Lassi Raivonen, Lena M Thorn, Carol Forsblom, Niina Sandholm, Peter Würtz, Per-Henrik Groop
medRxiv 2020.10.21.20215921; doi: https://doi.org/10.1101/2020.10.21.20215921
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Urinary metabolite profiling identifies biomarkers for risk of progression of diabetic nephropathy in 2,670 individuals with type 1 diabetes
Stefan Mutter, Erkka Valo, Viljami Aittomäki, Kristian Nybo, Lassi Raivonen, Lena M Thorn, Carol Forsblom, Niina Sandholm, Peter Würtz, Per-Henrik Groop
medRxiv 2020.10.21.20215921; doi: https://doi.org/10.1101/2020.10.21.20215921

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Endocrinology (including Diabetes Mellitus and Metabolic Disease)
Subject Areas
All Articles
  • Addiction Medicine (75)
  • Allergy and Immunology (194)
  • Anesthesia (54)
  • Cardiovascular Medicine (487)
  • Dentistry and Oral Medicine (89)
  • Dermatology (56)
  • Emergency Medicine (167)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (211)
  • Epidemiology (5648)
  • Forensic Medicine (3)
  • Gastroenterology (215)
  • Genetic and Genomic Medicine (855)
  • Geriatric Medicine (87)
  • Health Economics (229)
  • Health Informatics (755)
  • Health Policy (385)
  • Health Systems and Quality Improvement (250)
  • Hematology (105)
  • HIV/AIDS (181)
  • Infectious Diseases (except HIV/AIDS) (6437)
  • Intensive Care and Critical Care Medicine (387)
  • Medical Education (116)
  • Medical Ethics (28)
  • Nephrology (90)
  • Neurology (844)
  • Nursing (44)
  • Nutrition (141)
  • Obstetrics and Gynecology (161)
  • Occupational and Environmental Health (256)
  • Oncology (514)
  • Ophthalmology (162)
  • Orthopedics (44)
  • Otolaryngology (105)
  • Pain Medicine (45)
  • Palliative Medicine (21)
  • Pathology (149)
  • Pediatrics (247)
  • Pharmacology and Therapeutics (146)
  • Primary Care Research (112)
  • Psychiatry and Clinical Psychology (958)
  • Public and Global Health (2216)
  • Radiology and Imaging (374)
  • Rehabilitation Medicine and Physical Therapy (171)
  • Respiratory Medicine (310)
  • Rheumatology (109)
  • Sexual and Reproductive Health (80)
  • Sports Medicine (82)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (34)
  • Urology (42)